Phone: (212) 746-5788
Fax: (212) 746-0975
November 19, 2009 6:03 am
Oral Drug Is An Appropriate Option for Resistant UTIs
In a study, only 3% of ESBL-producing Escherhicia coli isolates were resistant to fosfomycin.